CFN Media Group (“CFN Media”), the leading agency and financial
media network dedicated to the North American cannabis industry,
announces publication of an article covering Cannabix
Technologies Inc. (CSE:BLO) (CNSX:BLO) (BLO.CN) (OTC:BLOZF)
and the development of its Cannabix Marijuana Breathalyzer
that aims to solve the dilemma of cannabis impairment testing with
an accurate, non-invasive, portable solution that could be used by
law enforcement at roadside.
Vermont recently passed a bill to legalize adult-use of
cannabis, with the new law set to take effect July 1. In an effort
to bolster public safety amid concerns of cannabis-impaired
driving, the state legislature introduced a bill to allow for the
use of saliva tests as an alternative to the current system, which
requires blood tests, a hospital visit, and a warrant. In a
decision that highlights the conundrum public health officials face
in regard to cannabis impairment, the Senate Judiciary
Committee recently rejected the bill amid concerns of
scientific validity, accuracy, and infringement on civil liberties.
The Cannabis Marijuana Breathalyzer, in advanced development,
offers a potential solution.
The Problems with Current Marijuana Testing
The chairman of the Vermont Senate Judiciary Committee, Sen.
Dick Sears, raised two main issues with the current reliance on
blood tests and the proposed saliva test solution. One is
technical, and the other pertains to the civil requirement for a
search warrant. The two problems intertwine into a vexing, circular
problem.
First, the technical side. “My reason [for opposing the bill]
was basically that the science isn’t there yet, and that I believe
in a few years they will have a standardized test, particularly for
marijuana, that would give us the amount that somebody would be
impaired by,” Sears said.
Second, the civil rights side. “I would be fine with the oral
fluid test if there was a warrant, like we have for blood. There’s
a warrant [required] to take blood. It’s one thing to take a breath
test, it’s another to take oral fluids or blood,” said Sears.
Unlike alcohol, which is absorbed and metabolized by humans in
predictable and documented ways, marijuana in the blood is a bit
more fickle. Different people metabolize the active ingredients at
different rates. Forms of THC, the psychoactive ingredient in
cannabis, are stored in fatty tissues and can be detected long
after ingestion, yet high concentrations of THC in the blood can
dissipate quickly when compared to alcohol. By the time a warrant
is obtained for either a blood or saliva sample those high levels
of THC may have come and gone, making the tests nearly useless in
many real-life field applications.
In short, there is a glaring need for accurate, timely testing
of THC levels that does not require a warrant to execute.
Fortunately, the current widespread and accepted use of the
breathalyzer for alcohol detection provides a blueprint for the
solution to the cannabis detection conundrum.
The Cannabix Marijuana Breathalyzer
Cannabix Technologies, in conjunction with researchers at the
University of Florida, has developed a potential solution.
Currently in advanced Beta 3.0 prototype form, the Cannabix
Marijuana Breathalyzer utilizes cutting edge spectrometry
technology to provide the sensitivity and accuracy necessary to
overcome the complex technical issues surrounding THC, and THC
metabolite, detection.
Again, it’s important to note the complexity of THC detection
due to the various forms the drug can take when metabolized.
Readers should click on the above-linked release to see a
discussion of 11-nor-9 vs. 11-hydroxy-delta-9 versions of THC and
their relative half-lives. Suffice to say, Cannabix is developing
technology with the ability to detect and distinguish various THC
metabolites which should go a long way toward distinguishing
between recent users and those who may simply have lingering THC in
their system.
Cannabix is diligently working its way through the scientific
end of things, fine-tuning and proving the device’s sensitivity and
reliability. The creation of a portable breathalyzer for THC would
be a critical development in overcoming the civil liberty questions
surrounding blood and saliva tests. With years of breathalyzer use
on the books as precedent, use of the device should assuage any
concerns that public health officials may have over violating civil
rights. Combined with the immediacy of the roadside breathalyzer
test, the Cannabix Marijuana Breathalyzer has the potential to
solve the cannabis testing conundrum once and for all.
Please follow the link to read the full
article: http://www.cannabisfn.com/recent-vermont-legislation-highlights-hurdles-surrounding-cannabis-impairment-testing/
About CFN Media
CFN Media (CannabisFN) is the leading agency and financial media
network dedicated to the global cannabis industry, helps companies
operating in the space attract investors, capital, and publicity.
Since 2013, private and public cannabis companies in the US and
Canada have relied on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or
entrepreneur: http://www.cannabisfn.com/featuredcompany
Download the CFN Media iOS mobile app to access the world of
cannabis from the palm of your
hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the
Apple App Store logo to receive a download link text on your
iPhone: http://www.cannabisfn.com
Disclaimer
CannabisFN.com is not an independent financial investment
advisor or broker-dealer. You should always consult with your own
independent legal, tax, and/or investment professionals before
making any investment decisions. The information provided
on http://www.cannabisfn.com (the ‘Site’) is either
original financial news or paid advertisements drafted by our
in-house team or provided by an affiliate. CannabisFN.com, a
financial news media and marketing firm enters into media buys or
service agreements with the companies that are the subject of the
articles posted on the Site or other editorials for advertising
such companies. We are not an independent news media
provider. We make no warranty or representation about the
information including its completeness, accuracy, truthfulness or
reliability and we disclaim, expressly and implicitly, all
warranties of any kind, including whether the Information is
complete, accurate, truthful, or reliable. As such, your use of the
information is at your own risk. Nor do we undertake any obligation
to update the items posted. CannabisFN.com received compensation
for producing and presenting high quality and sophisticated content
on CannabisFN.com along with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC,
which owns CannabisFN.com and CFN Media, has been hired to create
awareness. Please follow the link below to view our full disclosure
outlining our
compensation: http://www.cannabisfn.com/legal-disclaimer/
CFN MediaFrank Lane206-369-7050flane@cannabisfn.com
Cannabix Technologies (CSE:BLO)
Historical Stock Chart
From Sep 2024 to Oct 2024
Cannabix Technologies (CSE:BLO)
Historical Stock Chart
From Oct 2023 to Oct 2024